Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Johanna W. Van 'T Verlaat"'
Publikováno v:
Clinical Endocrinology. 33:619-624
SUMMARY Eleven patients with prolactin-producing pituitary adenomas were treated with the new non-ergot, long-acting dopamine agonist, CV 205–502, for a period of 2–18 months (mean 11 months). Tumour volumes ranged from 1–9 to 64 ml in seven pa
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 17:71-73
Nineteen patients, seven women and twelve men, with macroprolactinomas characterized by extrasellar extension and basal prolactin levels above 6 U/I were treated with 10-20 mg bromocriptine daily in four divided doses for a mean period of 3.4 years (
Autor:
Herman A.W. Hazewinkel, Ted S.G.A.M. van den Ingh, Björn P. Meij, Johanna W. Van ‘T Verlaat, George Voorhout
Publikováno v:
Veterinary surgery : VS. 26(4)
Objective— Assessment of a microsurgical technique for transsphenoidal hypophysectomy in dogs. Study Design— Prospective study using physical examination, pituitary function testing, computed tomography (CT), and histological examination at autop
Publikováno v:
Obstetrical & Gynecological Survey. 46:566-567
Publikováno v:
Acta Endocrinologica. 119:51-55
Five patients, 3 women and 2 men, with macroprolactinomas characterized by extrasellar extension and basal plasma prolactin levels ranging from 4.6 to 102 U/I received six monthly injections of 50–100 mg Parlodel LAR®, an injectable long-acting re
Publikováno v:
The Journal of clinical endocrinology and metabolism. 68(2)
Cushing's disease may originate from either the anterior pituitary lobe or the neurointermediate lobe, a major characteristic of the latter group being bromocriptine responsiveness. This study of two patients with Cushing's disease demonstrates that